Burden of Disease due to Nonalcoholic Fatty Liver Disease
- PMID: 32033757
- DOI: 10.1016/j.gtc.2019.09.007
Burden of Disease due to Nonalcoholic Fatty Liver Disease
Abstract
Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming the most common liver disease in both Western populations and other parts of the world. This review discusses the prevalence and incidence of NAFLD in various regions around the world. The methodology used to identify the epidemiology and classify the stages of the disease is described. The impact of the disease on individuals, looking at both liver-related and extrahepatic consequences of the disease, is then discussed. Finally, the economic and societal impact of the disease is discussed.
Keywords: Burden of disease; Epidemiology; Incidence; Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH); Prevalence.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.Hepatology. 2016 Nov;64(5):1577-1586. doi: 10.1002/hep.28785. Epub 2016 Sep 26. Hepatology. 2016. PMID: 27543837
-
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263. World J Gastroenterol. 2017. PMID: 29307986 Free PMC article. Review.
-
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.Clin Liver Dis. 2016 May;20(2):205-14. doi: 10.1016/j.cld.2015.10.001. Epub 2015 Dec 14. Clin Liver Dis. 2016. PMID: 27063264 Review.
-
Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future.Liver Int. 2018 Feb;38 Suppl 1:47-51. doi: 10.1111/liv.13643. Liver Int. 2018. PMID: 29427488 Review.
-
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.Hepatology. 2019 Jun;69(6):2672-2682. doi: 10.1002/hep.30251. Hepatology. 2019. PMID: 30179269 Review.
Cited by
-
Sodium-Glucose Co-Transporter 2 Inhibitors for Non-Alcoholic Fatty Liver Disease in Asian Patients With Type 2 Diabetes: A Meta-Analysis.Front Endocrinol (Lausanne). 2021 Feb 11;11:609135. doi: 10.3389/fendo.2020.609135. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33643221 Free PMC article.
-
Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD - An Umbrella Overview of Systematic Review of Meta-Analysis.J Clin Exp Hepatol. 2023 Jul-Aug;13(4):656-665. doi: 10.1016/j.jceh.2022.11.006. Epub 2022 Nov 19. J Clin Exp Hepatol. 2023. PMID: 37440949 Free PMC article. Review.
-
Kupffer Cells in Non-alcoholic Fatty Liver Disease: Friend or Foe?Int J Biol Sci. 2020 Jun 23;16(13):2367-2378. doi: 10.7150/ijbs.47143. eCollection 2020. Int J Biol Sci. 2020. PMID: 32760204 Free PMC article. Review.
-
A Class Effect Network Meta-analysis of Lipid Modulation in Non-alcoholic Steatohepatitis for Dyslipidemia.J Clin Transl Hepatol. 2022 Dec 28;10(6):1042-1049. doi: 10.14218/JCTH.2022.00095. Epub 2022 May 30. J Clin Transl Hepatol. 2022. PMID: 36381095 Free PMC article.
-
Retinoids in the Pathogenesis and Treatment of Liver Diseases.Nutrients. 2022 Mar 31;14(7):1456. doi: 10.3390/nu14071456. Nutrients. 2022. PMID: 35406069 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical